|
|
|
Volumn 53, Issue 8, 2012, Pages 747-752
|
|
[Feasibility and safety of chemotherapy for acute lymphoblastic leukemia in adolescents and young adults: Interim analysis of JALSG ALL202-U].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
ASPARAGINASE;
METHOTREXATE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ADULT;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
MAINTENANCE CHEMOTHERAPY;
MALE;
PHASE 2 CLINICAL TRIAL (TOPIC);
REMISSION;
REVIEW;
SAFETY;
ADOLESCENT;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
ASPARAGINASE;
CLINICAL TRIALS, PHASE II AS TOPIC;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
MAINTENANCE CHEMOTHERAPY;
MALE;
METHOTREXATE;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
REMISSION INDUCTION;
SAFETY;
YOUNG ADULT;
|
|
EID: 84874434790
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
